Prism AI Therapeutics cover photo
Prism AI Therapeutics

Prism AI Therapeutics

软件开发

Salt Lake City,Utah 633 位关注者

Drug and Biomarker Development with Quantum Mechanics-Based AI/ML

关于我们

Prism AI Therapeutics provides an AI-first multi-omics management platform that uniquely enables biotech companies and health systems to unlock the value of real-world multi-omic data and develop the next generation of drugs and biomarkers. The platform is powered by proprietary quantum mechanics-based AI/ML, and is supported by end-to-end global biospecimen sourcing and molecular profiling services. We and our partners have experimentally validated that our AI/ML is uniquely able to make accurate, precise, clinically actionable, and mechanistically interpretable discoveries from real-world multi-omic data. We excel in (i) discovering biomarkers of response and survival, disease models, and drug targets that consistently validate across studies and over time in federated, small-cohort, noisy, and high-dimensional data, (ii) integrating multi-omic data for discovery and validation of multi-modal predictors, (iii) separating the predictors from normal demographic variations, and (iv) removing systematic batch effects from the data. Let’s join forces to conquer disease.

网站
https://prism-ai.com/
所属行业
软件开发
规模
2-10 人
总部
Salt Lake City,Utah
类型
私人持股
创立
2024

地点

Prism AI Therapeutics员工

动态

相似主页

查看职位